Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
| Status: | Recruiting |
|---|---|
| Conditions: | Brain Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 12/6/2018 |
| Start Date: | September 26, 2000 |
| End Date: | September 2019 |
| Contact: | Nai-Kong Cheung, M.D., Ph.D. |
| Phone: | 646-888-2313 |
The purpose of this study is to find out the genetic and biochemical makeup of your
neuroblastic tumor, which influences its aggressiveness and the suitable therapy. These
research studies include surface marker analysis, cytogenetics, cancer genes,genome
sequencing, tumor growth-related genes and tumor growth in test tubes. Your blood, marrow,
and hematopoietic stem cell samples will also be tested for tumors or leukemia cells, and
your serum tested for anti-tumor antibodies.
neuroblastic tumor, which influences its aggressiveness and the suitable therapy. These
research studies include surface marker analysis, cytogenetics, cancer genes,genome
sequencing, tumor growth-related genes and tumor growth in test tubes. Your blood, marrow,
and hematopoietic stem cell samples will also be tested for tumors or leukemia cells, and
your serum tested for anti-tumor antibodies.
To collect tumor, marrow specimens prospectively to study the molecular-genetic makeup of
individual neuroblastic tumor and its metastasis by blood and marrow, and to correlate these
findings with clinical outcome, and to relate the signaling circuitry of neuroblastic tumors
to that of embryonic neuroectodermal cells. .
individual neuroblastic tumor and its metastasis by blood and marrow, and to correlate these
findings with clinical outcome, and to relate the signaling circuitry of neuroblastic tumors
to that of embryonic neuroectodermal cells. .
Inclusion Criteria:
- Neuroblastic tumors diagnosed in accordance with the International Neuroblastoma
Staging System
OR
- Clinically suspected neuroblastic tumors.
Exclusion Criteria:
We found this trial at
1
site
1275 York Ave
New York, New York 10021
New York, New York 10021
(212) 639-2000
Principal Investigator: Nai-Kong Cheung, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
